Hospira Inc. said its second-quarter profit more than doubled, as the provider of injectable drugs and infusion technologies posted higher sales.
from WSJ.com: US Business http://ift.tt/1oM2S0H
via IFTTT
from WSJ.com: US Business http://ift.tt/1oM2S0H
via IFTTT
No comments:
Post a Comment